Senvest Capital

Senvest Capital, headquartered in Montreal, Canada, operates as a holding company focused on investment management and direct investments in both public securities and private markets. Originally established as the Canadian distributor for Sensormatic Electronics, a pioneer in electronic security systems, Senvest has evolved significantly since its public listing in 1971. The company has diversified its portfolio by acquiring and managing various businesses, including one of Canada's first cable pay-TV channels, First Choice, which it successfully sold to Astral Media. Senvest Capital is also associated with Senvest Management, an employee-owned hedge fund that offers investment services primarily to pooled investment vehicles and corporations, emphasizing value stock investments through a blend of fundamental and quantitative analysis.

Richard Ron Mashaal

Founder, Co-CIO and CEO

10 past transactions

Northstar Realty Europe Corp.

Investor Activism in 2018
NorthStar Realty Europe Corp. is a European focused commercial real estate company with predominately prime office properties within key cities in Germany, the United Kingdom and France, organized as a REIT and managed by an affiliate of Colony Capital, Inc. (NYSE: CLNY), a leading global equity REIT with an embedded investment management platform.

Spotify

Series G in 2015
Spotify AB provides a digital music-streaming service that gives on-demand access of songs on devices, computers, mobiles, tablets, and home entertainment systems. Its services allow subscribers to search and discover music collections of friends, artists, and celebrities; build a personal collection playlist; and share music on Spotify, Facebook, Twitter, blog, and via email with friends. It also offers research and development services in Sweden. The company was founded in 2008 and is headquartered in Stockholm, Sweden. Spotify AB operates as a subsidiary of Spotify Technology S.A.

AIStorm

Private Placement in 2020
AIStorm is an AI startup that develops chipsets that can process data directly from devices. AIS technology is analog and mixed-signal technology. The sensor itself can deal with events, make decisions, and can perform complex analysis. The company was founded in 2011 and is headquartered in San Jose, California.

Bigfoot Biomedical

Private Placement in 2017
Bigfoot Biomedical, Inc., a health solution company, develops automated insulin delivery systems for people with Type 1 Diabetes (T1D). It develops a T1D Management System with cloud connectivity and human-centered-automation; and insulin pumps. Bigfoot Biomedical, Inc. was formerly known as SmartLoop Labs, Inc. and changed its name to in Bigfoot Biomedical, Inc. February 2015. The company was incorporated in 2014 and is based in Milpitas, California.

Bigfoot Biomedical

Series C in 2020
Bigfoot Biomedical, Inc., a health solution company, develops automated insulin delivery systems for people with Type 1 Diabetes (T1D). It develops a T1D Management System with cloud connectivity and human-centered-automation; and insulin pumps. Bigfoot Biomedical, Inc. was formerly known as SmartLoop Labs, Inc. and changed its name to in Bigfoot Biomedical, Inc. February 2015. The company was incorporated in 2014 and is based in Milpitas, California.

Bigfoot Biomedical

Series B in 2017
Bigfoot Biomedical, Inc., a health solution company, develops automated insulin delivery systems for people with Type 1 Diabetes (T1D). It develops a T1D Management System with cloud connectivity and human-centered-automation; and insulin pumps. Bigfoot Biomedical, Inc. was formerly known as SmartLoop Labs, Inc. and changed its name to in Bigfoot Biomedical, Inc. February 2015. The company was incorporated in 2014 and is based in Milpitas, California.

Unlimited

Seed Round in 2017
UNLIMITED is at the forefront in the design and creation of high-end Virtual Reality Experiences. VR is a revolutionary new medium - a mind-blowing hybrid between interactive media and immersive cinematic experiences. They offer branded and original VR content for immersive and interactive media, including films, TV series, games and advertising.

Bigfoot Biomedical

Series B in 2018
Bigfoot Biomedical, Inc., a health solution company, develops automated insulin delivery systems for people with Type 1 Diabetes (T1D). It develops a T1D Management System with cloud connectivity and human-centered-automation; and insulin pumps. Bigfoot Biomedical, Inc. was formerly known as SmartLoop Labs, Inc. and changed its name to in Bigfoot Biomedical, Inc. February 2015. The company was incorporated in 2014 and is based in Milpitas, California.

Medigus

Post in 2014
Medigus Ltd., a medical device company, develops, produces, and markets minimally invasive endo-surgical tools and direct visualization technology in the United States, Europe, Asia, and internationally. It offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease. Medigus Ltd. was founded in 1999 and is headquartered in Omer, Israel.

Bigfoot Biomedical

Series A in 2016
Bigfoot Biomedical, Inc., a health solution company, develops automated insulin delivery systems for people with Type 1 Diabetes (T1D). It develops a T1D Management System with cloud connectivity and human-centered-automation; and insulin pumps. Bigfoot Biomedical, Inc. was formerly known as SmartLoop Labs, Inc. and changed its name to in Bigfoot Biomedical, Inc. February 2015. The company was incorporated in 2014 and is based in Milpitas, California.